Cost-effectiveness of adjuvant chemotherapy for patients with high-risk stage II and stage III colon cancer in South Africa.

被引：0
|
作者：
Pumpalova, Yoanna S.
Rogers, Alexandra M.
Tan, Sarah Xinhui
Herbst, Candice-Lee
Ruff, Paul
Neugut, Alfred I.
Hur, Chin
机构：
[1] Columbia Univ, Irving Med Ctr, New York, NY USA
[2] Univ Witwatersrand, Johannesburg, South Africa
[3] Univ Witwatersrand, Fac Hlth Sci, Johannesburg, South Africa
[4] Columbia Univ, Herbert Irving Comprehens Caner Ctr, New York, NY USA
[5] Columbia Univ, Med Ctr, New York, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2022年 / 40卷 / 16期
基金：
美国国家卫生研究院;
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
6599
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa
    Tan, Sarah Xinhui
    Pumpalova, Yoanna
    Rogers, Alexandra M. M.
    Bhatt, Kishan
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I. I.
    Hur, Chin
    [J]. CANCER MEDICINE, 2023, 12 (14): : 15515 - 15529
  • [2] Modeling the Cost-Effectiveness of Adjuvant Chemotherapy for Stage III Colon Cancer in South African Public Hospitals
    Pumpalova, Yoanna
    Rogers, Alexandra M.
    Tan, Sarah Xinhui
    Herbst, Candice-lee
    Ruff, Paul
    Neugut, Alfred I.
    Hur, Chin
    [J]. JCO GLOBAL ONCOLOGY, 2021, 7 : 1730 - 1741
  • [3] ADJUVANT CHEMOTHERAPY IN HIGH-RISK STAGE II COLON CANCER.
    Lightner, A.
    Glyn, T.
    Parker, M.
    Tse, C.
    Abdelsattar, Z.
    Larson, D.
    Mathis, K.
    [J]. DISEASES OF THE COLON & RECTUM, 2016, 59 (05) : E293 - E293
  • [4] Adjuvant chemotherapy for high-risk stage II and stage III colon cancer: timing of initiation and optimal duration
    Cruz, Jan Paolo M.
    Pales, Chris George C.
    Kim, Kwang Min
    Kim, Young Wan
    [J]. JOURNAL OF BUON, 2018, 23 (03): : 568 - 573
  • [5] Duration of oxaliplatin-based adjuvant chemotherapy in patients with Stage III or high-risk Stage II resected colon cancer
    Moretto, Roberto
    Falcone, Alfredo
    Cremolini, Chiara
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2020, 146 (09) : 2652 - 2654
  • [6] Effectiveness of oral fluoropyrimidine monotherapy as adjuvant chemotherapy for high-risk stage II colon cancer
    Cho, Jung Rae
    Lee, Keun-Wook
    Oh, Heung-Kwon
    Kim, Jin Won
    Kim, Ji-Won
    Kim, Duck-Woo
    Kim, Jee Hyun
    Kang, Sung-Bum
    [J]. ANNALS OF SURGICAL TREATMENT AND RESEARCH, 2022, 102 (05) : 271 - 280
  • [7] Microsatellite Status Predicts Effectiveness of Adjuvant Chemotherapy in High-Risk Stage II Colon Cancer
    Krishnamurty, Devi Mukkai
    Park, Yu-Soon A.
    Tashjian, Nara
    Aurit, Sarah J.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2019, 229 (04) : S65 - S66
  • [8] Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer
    Cakar, B.
    Varol, U.
    Junushova, B.
    Muslu, U.
    Oner, P. Gursoy
    Surmeli, Z. Gokhan
    Cirak, Y.
    Karaca, B.
    Sezgin, C.
    Karabulut, B.
    Uslu, R.
    [J]. JOURNAL OF BUON, 2013, 18 (02): : 372 - 376
  • [9] Cost-effectiveness of adjuvant chemotherapy for stage III colon cancer in the South African public healthcare setting.
    Pumpalova, Yoanna S.
    Rogers, Alexandra M.
    Tan, Sarah Xinhui
    Herbst, Candice-Lee
    Ruff, Paul
    Neugut, Alfred I.
    Hur, Chin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [10] The effect of gaps in chemotherapy on survival in patients with high-risk stage II and stage III colon cancer
    Sada, Yvonne
    Duan, Zhigang
    El-Serag, Hashem
    Davila, Jessica
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (34)
12345